共 50 条
- [41] Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed GlioblastomaJOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2712 - 2718Stupp, RogerHegi, Monika E.Neyns, BartGoldbrunner, RolandSchlegel, UweClement, Paul M. J.Grabenbauer, Gerhard G.Ochsenbein, Adrian F.Simon, MatthiasDietrich, Pierre-YvesPietsch, TorstenHicking, ChristineTonn, Joerg-ChristianDiserens, Annie-ClairePica, AlessiaHermisson, MirjamKrueger, StefanPicard, MartinWeller, Michael
- [42] Mature results of a phase I/IIA trial of the integrin inhibitor cilengitide (EMD121974) added to standard concomitant and adjuvant temozolomide and radiotherapy (TMZ/RT) for newly diagnosed glioblastoma (GBM)NEURO-ONCOLOGY, 2007, 9 (04) : 517 - 517Stupp, RogerGoldbrunner, RolandNeyns, BartSchlegel, UweClement, PaulGrabenbauer, GerhardHegi, MonikaNippgen, JohannesPicard, MartinWeller, Michael
- [43] A PHASE I TRIAL OF TIPIFARNIB WITH RADIATION THERAPY, WITH AND WITHOUT TEMOZOLOMIDE, FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMAINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1422 - 1427Nghiemphu, Phioanh LeiaWen, Patrick Y.Lamborn, Kathleen R.Drappatz, JanRobins, H. IanFink, KarenMalkin, Mark G.Lieberman, Frank S.DeAngelis, Lisa M.Torres-Trejo, AlejandroChang, Susan M.Abrey, LaurenFine, Howard A.Demopoulos, AlexisLassman, Andrew B.Kesari, SantoshMehta, Minesh P.Prados, Michael D.Cloughesy, Timothy F.
- [44] Tetrahydrocannabinol (THC) / cannabidiol (CBD) oral solution in combination with temozolomide (TMZ) and radiotherapy (RT) in patients with newly diagnosed glioblastoma: Phase Ib GEINO-1601 trialANNALS OF ONCOLOGY, 2024, 35 : S411 - S411Sepulveda, J. M.Alonso, M.Velilla, G.Garcia Grove, C.Martinez-Garcia, M.Foro, P.Garcia Gonzalez, C.Muriel Lopez, C.Luque, R.Luque, N.Stradella, A.Sabat Viltro, P.Navarro Martin, M.Rivas Lopez, B.Guzman, M.Tovar-Ambel, E.Velasco, G.Sanchez Morillas, R.Fuster Salva, J.
- [45] Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II studyANNALS OF ONCOLOGY, 2023, 34 : S392 - S392Vieito Villar, M.Sepulveda Sanchez, J. M.Moreno Garcia, V.Lombardi, G.Stradella, A.Dahlrot, R. H.Haslund, C. A.Geurts, M.Pineda, E.Brandal, P.De Vos, F. Y. F. L.Vaz Salgado, M. A.Martinez Garcia, M.Macchini, M.Amoroso, B.Sanchez, T.Hanna, B.Li, X.Nikolova, Z.Simonelli, M.
- [46] Phase II study of combination BCNU and temozolomide (TMZ) prior to radiotherapy in newly diagnosed anaplastic oligodendroglial tumorsJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Chinot, O. L.Sanson, M.Barrie, M.Fabbro, M.Taillandier, L.Honnorat, J.Figarella-Branger, D.Mokhtari, K.Guillevin, R.Hoang-Xuan, K.
- [47] GEINO 1402: A phase Ib dose-escalation study followed by an extension phase to evaluate safety and efficacy of crizotonib in combination with temozolomide (TMZ) and radiotherapy (RT) in patients with newly diagnosed glioblastoma (GB): Results of the dose-escalation phase.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Garcia, Maria MartinezGil, Miguel J. GilLosada, Estela PinedaVelasco, GuillermoAlameda, FrancescTaus, AlvaroCapellades, JaumeMarquez-Martin, AnaSarmiento, BeatrizMesia Barroso, CarlosBruna Escuer, JordiVerger, EugeniaHernandez-Lain, AurelioGuzman, ManuelManuel Sepulveda, Juan
- [48] PHASE II STUDY OF BEVACIZUMAB, TEMOZOLOMIDE, AND HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY (HFSRT) FOR NEWLY DIAGNOSED GLIOBLASTOMANEURO-ONCOLOGY, 2011, 13 : 59 - 60Omuro, AntonioBeal, KathrynCorrea, DeniseChan, TimothyDeAngelis, LisaGavrilovic, IgorNolan, CraigHormigo, AdiliaLassman, Andrew B.Kaley, ThomasMellinghoff, IngoGrommes, ChristianPanageas, KathrynReiner, AnnBarradas, RenataAbrey, LaurenGutin, Philip
- [49] Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapyJournal of Neuro-Oncology, 2009, 95 : 393 - 400Jennifer A. QuinnSara Xiaoyin JiangDavid A. ReardonAnnick DesjardinsJames J. VredenburghAllan H. FriedmanJohn H. SampsonRoger E. McLendonJames E. HerndonHenry S. Friedman
- [50] Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapyJOURNAL OF NEURO-ONCOLOGY, 2009, 95 (03) : 393 - 400Quinn, Jennifer A.Jiang, Sara XiaoyinReardon, David A.Desjardins, AnnickVredenburgh, James J.Friedman, Allan H.Sampson, John H.McLendon, Roger E.Herndon, James E., IIFriedman, Henry S.